文献速递产科生殖医学母胎医学

枸橼酸氯米芬与神经管缺陷:对照观察性研究的荟萃分析

Clomiphene citrate and neural tube defects: a meta-analysis of controlled observational studies.
PubMed 文献 · BJOG · 2019-05-23

该荟萃分析纳入13项对照观察性研究、共218819例妊娠,评估围受孕期枸橼酸氯米芬(CC)暴露与神经管缺陷(NTD)风险。合并比值比为1.21(95%CI 0.88-1.66),无统计学显著性,研究间异质性I²=26%,漏斗图及不对称检验未提示发表偏倚。作者结论称CC暴露与NTD风险增加21%相关,但该增加无统计学显著性。

要点

  • 围受孕期CC暴露与NTD风险的合并OR为1.21(95%CI 0.88-1.66),无统计学显著性。
  • 研究间异质性I²=26%,漏斗图及不对称检验未提示发表偏倚。
  • 作者结论:CC暴露与NTD风险增加21%相关,但该增加无统计学显著性。

核心结论

  • 作者结论称,妊娠前或妊娠早期暴露于CC与NTD风险增加21%相关,但该增加无统计学显著性。

研究设计与样本

  • 对比较队列研究和病例对照研究进行更新的定量荟萃分析,检索MEDLINE、Web of Science和Scopus(2018年10月)。
  • 纳入13项符合入选标准的比较队列和病例对照研究,共计218819例妊娠。
  • 采用随机效应模型计算合并效应量及相应95%CI,比较暴露与未暴露于CC的妊娠间NTD风险。

主要发现

  • 围受孕期CC暴露与NTD风险增加无显著关联,合并比值比1.21(95%CI 0.88-1.66)。
  • 研究间未观察到异质性,I²=26%。
  • 漏斗图及不对称检验未提示发表偏倚。

关键数值与推荐

  • 纳入标准为探讨围受孕期CC暴露后NTD风险的比较队列研究和病例对照研究。
  • 合并比值比1.21(95%CI 0.88-1.66),异质性I²=26%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: At the end of the 1980s, several studies suggested a potential increased risk of neural tube defects (NTDs) with ovulation induction/fertility drugs, especially with clomiphene citrate (CC). A previous meta-analysis of observational studies evaluating the risk of NTDs associated with the use of CC performed in 1995 found a risk ratio of 1.08 (95% CI 0.76-1.51). Since then, additional studies have been published and the risk of NTDs associated with periconceptional CC exposure may have changed. OBJECTIVE: To perform an updated quantitative meta-analysis of the risk of NTDs associated with periconceptional CC exposure. SEARCH STRATEGY: MEDLINE, Web of Science, and Scopus were searched (October 2018). SELECTION CRITERIA: Comparative cohort and case-control studies investigating the risk of NTDs after periconceptional CC exposure. DATA COLLECTION AND ANALYSIS: Pooled effect sizes with corresponding 95% CIs were calculated using random effects models, comparing the risk of NTDs between pregnancies exposed and not exposed to CC. MAIN RESULTS: Thirteen studies met the inclusion criteria, totalling 218 819 pregnancies. Periconceptional exposure to CC was not significantly associated with an increased risk of NTDs (pooled odds ratio 1.21, 95% CI 0.88-1.66). No heterogeneity between studies was observed (I2 = 26%). A funnel plot and asymmetry test were not suggestive of publication bias. CONCLUSION: Our meta-analysis confirms that exposure to CC before or in early pregnancy was associated with a 21% increased risk of NTD in relation to CC exposure; however, this increased risk is not statistically significant. TWEETABLE ABSTRACT: A new meta-analysis finds that clomiphene citrate exposure before or in early pregnancy is not associated with an increased risk of NTDs.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Auffret M, Cottin J, Vial T, et al. Clomiphene citrate and neural tube defects: a meta-analysis of controlled observational studies. BJOG. 2019. PMID: 31006176. doi:10.1111/1471-0528.15800

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。